← Back to Search

NNRTI

Doravirine for Human Immunodeficiency Virus Infection

Phase 4
Waitlist Available
Research Sponsored by Clinique du Quartier Latin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

Study Summary

This trial will test the safety and efficacy of switching from the drug etravirine to doravirine in patients with resistance to multiple HIV medications who are also taking other ARV drugs. The other ARV drugs (protease inhibitor, entry inhibitor and integrase inhibitor) will not be changed. The trial will be performed at only two sites.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of subjects who maintain virologic control .

Side effects data

From 2020 Phase 3 trial • 15 Patients • NCT04079452
7%
Diarrhea
7%
Thoracic pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
Doravirine+TAF/FTC Arm (Single Arm)

Trial Design

1Treatment groups
Experimental Treatment
Group I: switch from etravirine to doravirineExperimental Treatment1 Intervention
switches to doravirine,
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Etravirine
FDA approved

Find a Location

Who is running the clinical trial?

Clinique du Quartier LatinLead Sponsor
Merck Frosst Canada Ltd.Industry Sponsor
29 Previous Clinical Trials
12,367 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
HIV Switch Trial in Experienced Patients With Multiple Class Resistance Including NNRTI Resistance
Benoit Trottier 2020. "HIV Switch Trial in Experienced Patients With Multiple Class Resistance Including NNRTI Resistance". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04334551.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top